• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-19a 作为癌症患者的预后指标:一项荟萃分析。

MiR-19a as a prognostic indicator for cancer patients: a meta-analysis.

机构信息

Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China

出版信息

Biosci Rep. 2019 May 14;39(5). doi: 10.1042/BSR20182370. Print 2019 May 31.

DOI:10.1042/BSR20182370
PMID:31015372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6522715/
Abstract

MiR-19a was aberrantly expressed in various types of cancers and was observed to be potentially associated with the prognosis of cancer patients. The present analysis aims to elucidate its precise predictive value in various human malignancies. Online electronic searches of PubMed, Web of Science (WOS), Embase in English and VIP, Wanfang, SinoMed, and the China National Knowledge Infrastructure (CNKI) in Chinese up to September 8, 2018 were conducted. As a result, in overall analysis, a significant association was identified between miR-19a levels and OS (HRs = 2.31, CI: 1.11-4.83). The relation of miR-19a expression to OS was further recognized by fixed model within the studies of sample size less than 150 (HRs = 1.68, CI: 1.35-2.08), NOS scores greater than or equal to 8 (HRs = 1.53, CI: 1.13-2.06) or less than 8 (HRs = 1.89, CI: 1.58-2.27), specimen derived from tumor (HRs = 1.73, CI: 1.42-2.12) or blood (HRs = 1.87, CI: 1.46-2.40) and the patients of osteosarcoma (HRs = 7.17, CI: 5.04-10.21). Sensitivity analyses revealed no significant results. The association between miR-19a expression level and DFS was also found to be significant (HRs = 2.03, CI: 1.13-3.66). Correlations between miR-19a levels and clinicopathological features were examined and revealed that lymph node metastasis was significantly associated with miR-19a expression levels (OR = 0.565, CI: 0.346-0.921). Summarily, the over expression of miR-19a was an underlying risk of poor prognosis in many human malignancies, especially in osteosarcoma. Moreover, elevated miR-19a expression was linked to the potential of lymph node metastasis.

摘要

miR-19a 在多种类型的癌症中表达异常,并且观察到其与癌症患者的预后可能相关。本分析旨在阐明其在各种人类恶性肿瘤中的精确预测价值。以英文在线检索 PubMed、Web of Science(WOS)、Embase 和中文的维普、万方、中国生物医学文献数据库(CBM)、中国知网(CNKI),检索时限均为 2018 年 9 月 8 日。总体分析结果显示,miR-19a 水平与 OS 之间存在显著相关性(HRs=2.31,95%CI:1.11-4.83)。在样本量小于 150 的研究中,采用固定模型进一步确认 miR-19a 表达与 OS 的关系(HRs=1.68,95%CI:1.35-2.08),或在 NOS 评分大于或等于 8(HRs=1.53,95%CI:1.13-2.06)或小于 8(HRs=1.89,95%CI:1.58-2.27)、来源于肿瘤(HRs=1.73,95%CI:1.42-2.12)或血液(HRs=1.87,95%CI:1.46-2.40)的标本或骨肉瘤患者(HRs=7.17,95%CI:5.04-10.21)中,miR-19a 表达与 OS 之间存在显著相关性。敏感性分析结果无显著差异。miR-19a 表达水平与 DFS 之间也存在显著相关性(HRs=2.03,95%CI:1.13-3.66)。还检查了 miR-19a 水平与临床病理特征之间的相关性,结果表明淋巴结转移与 miR-19a 表达水平显著相关(OR=0.565,95%CI:0.346-0.921)。综上所述,miR-19a 的过表达是许多人类恶性肿瘤不良预后的潜在危险因素,尤其是骨肉瘤。此外,miR-19a 表达水平升高与淋巴结转移的可能性有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cecd/6522715/b1fd8d9c82d3/bsr-39-bsr20182370-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cecd/6522715/8dbcdc164d91/bsr-39-bsr20182370-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cecd/6522715/2ee857351e24/bsr-39-bsr20182370-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cecd/6522715/d71202b5f203/bsr-39-bsr20182370-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cecd/6522715/b1fd8d9c82d3/bsr-39-bsr20182370-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cecd/6522715/8dbcdc164d91/bsr-39-bsr20182370-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cecd/6522715/2ee857351e24/bsr-39-bsr20182370-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cecd/6522715/d71202b5f203/bsr-39-bsr20182370-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cecd/6522715/b1fd8d9c82d3/bsr-39-bsr20182370-g4.jpg

相似文献

1
MiR-19a as a prognostic indicator for cancer patients: a meta-analysis.miR-19a 作为癌症患者的预后指标:一项荟萃分析。
Biosci Rep. 2019 May 14;39(5). doi: 10.1042/BSR20182370. Print 2019 May 31.
2
Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.微小RNA-19a的高表达预示骨肉瘤患者预后不良。
Pathol Res Pract. 2017 Mar;213(3):194-198. doi: 10.1016/j.prp.2016.12.020. Epub 2016 Dec 29.
3
Prognostic and clinicopathological significance of MicroRNA-153 in human cancers: A meta-analysis.微小RNA-153在人类癌症中的预后及临床病理意义:一项荟萃分析
Medicine (Baltimore). 2020 Nov 13;99(46):e22833. doi: 10.1097/MD.0000000000022833.
4
Prognostic and clinicopathological significance of miR-638 in cancer patients: A meta-analysis.miR-638 在癌症患者中的预后及临床病理意义:一项荟萃分析。
Medicine (Baltimore). 2021 Apr 16;100(15):e25441. doi: 10.1097/MD.0000000000025441.
5
Association between PTEN and clinical-pathological features of osteosarcoma.PTEN 与骨肉瘤临床病理特征的关系。
Biosci Rep. 2019 Jul 18;39(7). doi: 10.1042/BSR20190954. Print 2019 Jul 31.
6
Investigation of MiR-92a as a Prognostic Indicator in Cancer Patients: a Meta-Analysis.miR-92a作为癌症患者预后指标的研究:一项荟萃分析
J Cancer. 2019 Jul 23;10(18):4430-4441. doi: 10.7150/jca.30313. eCollection 2019.
7
miR-21 predicts poor prognosis in patients with osteosarcoma.微小RNA-21可预测骨肉瘤患者的预后不良。
Br J Biomed Sci. 2016 Oct;73(4):158-162. doi: 10.1080/09674845.2016.1220710.
8
The clinical prognostic significance of miR-140-5p expression in patients with cancer: A Meta and Bioinformatic analysis.miR-140-5p 表达在癌症患者中的临床预后意义:Meta 和生物信息学分析。
Pathol Res Pract. 2024 Sep;261:155475. doi: 10.1016/j.prp.2024.155475. Epub 2024 Jul 25.
9
A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.四血清 miRNA 标志物panel 可作为骨肉瘤的潜在诊断生物标志物。
Int J Clin Oncol. 2019 Aug;24(8):976-982. doi: 10.1007/s10147-019-01433-x. Epub 2019 May 20.
10
Low microRNA-139 expression associates with poor prognosis in patients with tumors: A meta-analysis.低表达 microRNA-139 与肿瘤患者预后不良相关:一项荟萃分析。
Hepatobiliary Pancreat Dis Int. 2019 Aug;18(4):321-331. doi: 10.1016/j.hbpd.2018.09.016. Epub 2018 Sep 26.

引用本文的文献

1
Circulating non-coding RNAs as a tool for liquid biopsy in solid tumors.循环非编码RNA作为实体瘤液体活检的工具
Epigenomics. 2025 Apr;17(5):335-358. doi: 10.1080/17501911.2025.2467021. Epub 2025 Mar 5.
2
The Role of miRNAs in the Development, Proliferation, and Progression of Endometrial Cancer.miRNAs 在子宫内膜癌的发生、增殖和进展中的作用。
Int J Mol Sci. 2023 Jul 15;24(14):11489. doi: 10.3390/ijms241411489.
3
miR-19a mediates the mechanism by which SPHK2 regulates hypopharyngeal squamous cell carcinoma progression through the PI3K/AKT axis.

本文引用的文献

1
microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.microRNA-19a-3p 通过 PTEN/Akt 通路促进肝癌的肿瘤转移和化疗耐药性。
Biomed Pharmacother. 2018 Sep;105:1147-1154. doi: 10.1016/j.biopha.2018.06.097. Epub 2018 Jun 21.
2
Prognostic Role of Hypoxia-Inducible Factor-2α Tumor Cell Expression in Cancer Patients: A Meta-Analysis.缺氧诱导因子-2α肿瘤细胞表达在癌症患者中的预后作用:一项荟萃分析。
Front Oncol. 2018 Jun 11;8:224. doi: 10.3389/fonc.2018.00224. eCollection 2018.
3
Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.
微小RNA-19a介导鞘氨醇激酶2通过磷脂酰肌醇-3-激酶/蛋白激酶B轴调控下咽鳞状细胞癌进展的机制。
Am J Cancer Res. 2023 Jun 15;13(6):2342-2359. eCollection 2023.
4
Prognostic Value of the miR-17~92 Cluster in Chronic Lymphocytic Leukemia.miR-17~92 簇在慢性淋巴细胞白血病中的预后价值。
Int J Mol Sci. 2023 Jan 15;24(2):1705. doi: 10.3390/ijms24021705.
5
MiR-19a suppresses ferroptosis of colorectal cancer cells by targeting IREB2.miR-19a 通过靶向 IREB2 抑制结直肠癌细胞的铁死亡。
Bioengineered. 2022 May;13(5):12021-12029. doi: 10.1080/21655979.2022.2054194.
6
<em>miR-19a</em> targeting <em>CLCA4</em> to regulate the proliferation, migration, and invasion of colorectal cancer cells.miR-19a 靶向 CLCA4 调节结肠直肠癌细胞的增殖、迁移和侵袭。
Eur J Histochem. 2022 Mar 10;66(1):3381. doi: 10.4081/ejh.2022.3381.
7
Hypoxia Enhances Activity and Malignant Behaviors of Colorectal Cancer Cells through the STAT3/MicroRNA-19a/PTEN/PI3K/AKT Axis.缺氧通过 STAT3/miRNA-19a/PTEN/PI3K/AKT 轴增强结直肠癌细胞的活性和恶性行为。
Anal Cell Pathol (Amst). 2021 Nov 9;2021:4132488. doi: 10.1155/2021/4132488. eCollection 2021.
8
Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer.外泌体 miR-19a 和 IBSP 协同诱导雌激素受体阳性乳腺癌溶骨性骨转移。
Nat Commun. 2021 Aug 31;12(1):5196. doi: 10.1038/s41467-021-25473-y.
9
Role of miRNA-19a in Cancer Diagnosis and Poor Prognosis.微小RNA-19a在癌症诊断及预后不良中的作用
Int J Mol Sci. 2021 Apr 29;22(9):4697. doi: 10.3390/ijms22094697.
10
Up-regulation of miR-155 potentiates CD34+ CML stem/progenitor cells to escape from the growth-inhibitory effects of TGF-ß1 and BMP signaling.miR-155的上调增强了CD34+慢性粒细胞白血病干/祖细胞逃避转化生长因子-β1(TGF-ß1)和骨形态发生蛋白(BMP)信号传导的生长抑制作用的能力。
EXCLI J. 2021 Apr 15;20:748-763. doi: 10.17179/excli2021-3404. eCollection 2021.
先天性或获得性骨髓衰竭疾病患者仅治疗性血小板输注策略与预防性血小板输注策略的比较。
Cochrane Database Syst Rev. 2018 May 14;5(5):CD012342. doi: 10.1002/14651858.CD012342.pub2.
4
Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.由MiR-19a-3p调控的下调型PITX1通过影响转录激活的PDCD5促进细胞恶性转化并预测胃癌的不良预后。
Cell Physiol Biochem. 2018;46(6):2215-2231. doi: 10.1159/000489590. Epub 2018 May 3.
5
Prognostic role of RDW in hematological malignancies: a systematic review and meta-analysis.红细胞分布宽度(RDW)在血液系统恶性肿瘤中的预后作用:一项系统评价和荟萃分析
Cancer Cell Int. 2018 Apr 23;18:61. doi: 10.1186/s12935-018-0558-3. eCollection 2018.
6
MicroRNA-19a and microRNA-19b promote the malignancy of clear cell renal cell carcinoma through targeting the tumor suppressor RhoB.微小RNA-19a和微小RNA-19b通过靶向肿瘤抑制因子RhoB促进透明细胞肾细胞癌的恶性发展。
PLoS One. 2018 Feb 23;13(2):e0192790. doi: 10.1371/journal.pone.0192790. eCollection 2018.
7
MicroRNA-19a acts as a prognostic marker and promotes prostate cancer progression via inhibiting VPS37A expression.微小RNA-19a作为一种预后标志物,通过抑制VPS37A的表达促进前列腺癌进展。
Oncotarget. 2017 Dec 6;9(2):1931-1943. doi: 10.18632/oncotarget.23026. eCollection 2018 Jan 5.
8
High circulating miR-18a, miR-20a, and miR-92a expression correlates with poor prognosis in patients with non-small cell lung cancer.高循环 miR-18a、miR-20a 和 miR-92a 的表达与非小细胞肺癌患者的不良预后相关。
Cancer Med. 2018 Jan;7(1):21-31. doi: 10.1002/cam4.1238. Epub 2017 Dec 21.
9
Prognostic role of miR-17-92 family in human cancers: evaluation of multiple prognostic outcomes.miR-17-92家族在人类癌症中的预后作用:多种预后结果的评估
Oncotarget. 2017 Jul 8;8(40):69125-69138. doi: 10.18632/oncotarget.19096. eCollection 2017 Sep 15.
10
Prognostic value of high-expression of miR-17-92 cluster in various tumors: evidence from a meta-analysis.miR-17-92 簇高表达在各种肿瘤中的预后价值:来自荟萃分析的证据。
Sci Rep. 2017 Aug 21;7(1):8375. doi: 10.1038/s41598-017-08349-4.